Dr. Parameswaran Hari | CureTalks
Dr. Parameswaran Hari is the Clinical Director of the Adult Bone Marrow Transplant Program and Associate Professor of Medicine, Division of Hematology and Oncology at the Medical College of Wisconsin. According to myelomasurvival.com, Dr. Hari has the best 2 and 3 year survival rates for myeloma patients. Myeloma patients under Dr. Hari's care at the Medical College of Wisconsin are 13 times more likely to survive 2 years and 7.2 times more likely to survive 3 years than in an average SEER facility. The SEER(Surveillance, Epidemiology and End Results) data from the National Cancer Institute provides survival data for many cancers including multiple myeloma.
Related Talks
Post-Transplant Outcomes in High Risk Multiple Myeloma
Treatment of patients with myeloma has changed dramatically in the past years due to development of new agents and myeloma specific targets. Despite…
ASH 2014 Myeloma Updates with Dr. Parameswaran Hari
We bring you myeloma updates from the upcoming 56th Annual ASH (American Society of Hematologists) Meeting and Exposition. Tune in to learn what…
Improvements in Myeloma Survival with Dr. Parameswaran Hari
You are 7 times more likely to survive three years in Dr. Hari's care than the care of an average facility that reports…